STEPHEN KAJENCKI: Open Payments
NPI 1073521753 · MANSFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 10 payments from 6 companies in 2025. Trend: 2023 $511 · 2024 $139 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $102 |
| Lilly USA, LLC | 2 | $47 |
| Verona Pharma, Inc. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: Ozempic, MOUNJARO, Ohtuvayre, JARDIANCE, Rybelsus, APTIMA, ZORYVE.
Industry payments across MA — which companies pay providers there.
